Large‐for‐gestational age · women with gestational diabetes mellitus
Glibenclamide showed no clear difference in large‐for‐gestational age compared with acarbose ‐ neonatal outcomes (low certainty).
1 finding from 1 review
Perinatal mortality · women with gestational diabetes mellitus
1 finding from 1 review
Death or serious morbidity composite · women with gestational diabetes mellitus
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Neonatal hypoglycaemia · women with gestational diabetes mellitus
Glibenclamide showed no clear difference in neonatal hypoglycaemia compared with acarbose ‐ neonatal outcomes (low certainty).
1 finding from 1 review
Adiposity ‐ not reported · women with gestational diabetes mellitus
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Diabetes ‐ not reported · women with gestational diabetes mellitus
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Neurosensory disability in later childhood ‐ not measured · women with gestational diabetes mellitus
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Ataxia rating score ICARS; range 0 to 100) · people with Friedreich ataxia
1 finding from 1 review
Ejection fraction · people with Friedreich ataxia
1 finding from 1 review
End‐diastolic interventricular septal thickness (IVSTd) Measured in mm · people with Friedreich ataxia
1 finding from 1 review
Left ventricular mass · people with Friedreich ataxia
1 finding from 1 review
Survival (not measured) · people with Friedreich ataxia
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Severe adverse events · people with Friedreich ataxia
Antioxidant showed no clear difference in severe adverse events compared with placebo (low certainty).
1 finding from 1 review
Early seizures (number of seizures) · people with traumatic head injuries
Antiepileptic drugs may leads to lower early seizures Count of events compared with placebo or standard care (low certainty).
1 finding from 1 review
Seizures · people with traumatic head injuries
1 finding from 1 review
Early seizures (number of seizures) · people with traumatic head injuries
Anti‐epileptic drugs showed no clear difference in early seizure Counts of events compared with other anti‐epileptic drugs (low certainty).
1 finding from 1 review
Late seizures (number of seizures) · people with traumatic head injuries
Anti‐epileptic drugs showed no clear difference in late seizure Counts of events compared with other anti‐epileptic drugs (moderate certainty).
1 finding from 1 review
All‐cause mortality · people with traumatic head injuries
Anti‐epileptic drugs showed no clear difference in all‐cause mortality compared with other anti‐epileptic drugs (moderate certainty).
1 finding from 1 review
Seizures · people with traumatic head injuries
1 finding from 1 review
Late seizures (number of seizures) · people with traumatic head injuries
It is very uncertain whether antiepileptic drugs changes late seizures Count of events compared with placebo or standard care (very low certainty).
1 finding from 1 review